Top Markets
Coin of the day
Restart Life Sciences Corp. Restart Life Sciences Corp.

Restart Life Sciences Corp.

HEAL
株式のランク #37250
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
株価
$0.05137558
最終同期: 2026-08-13
時価総額
$1.88M
変化(1日)
0.00%
変化(1年)
-11.66%
CA
取引 Restart Life Sciences Corp. (HEAL)

カテゴリー

Restart Life Sciences Corp.(HEAL)のEPS
2026 時点のEPS TTM: 0
Restart Life Sciences Corp.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Restart Life Sciences Corp.のEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS